Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing ...

Rebecca Chacko, MD, discussed exciting advancements in breast cancer care and the future role of emerging therapeutic strategies for early recurrence detection, as part of her panelist role at the ...

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older ...

The Supreme Court decision in Medina v Planned Parenthood South Atlantic and the subsequent passing of the budget bill leave ...

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...

The potential of health care technology has been disconnected from patients, making those innovations barriers rather than means of improving access and communication.

Rebecca Chacko, MD, discusses key breast cancer care challenges, including treatment access delays and the importance of open patient communication, as highlighted at the Detroit Institute for ...

Flatiron Health expands its international oncology research network, enhancing real-world data use to improve patient ...

Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...